Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers
Udo Hoffmann(Duke Medical Center), Steven Grinspoon(Massachusetts General Hospital), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Kenneth C. Williams(Boston College), Edgar T. Overton(University of Alabama at Birmingham), Michael T. Osborne(Harvard University), A S Ivanov(Massachusetts General Hospital), John Sukumar Aluru(Massachusetts General Hospital), Devvora Olalere(Massachusetts General Hospital), Katharine Cooper‐Arnold(National Institutes of Health), Pamela S. Douglas(Duke University), Nadja Arifovic(Massachusetts General Hospital), Elizabeth Adami(Massachusetts General Hospital), Michael T. Lu(Cancer Research And Biostatistics), Patrice Desvigne‐Nickens(National Heart Lung and Blood Institute), Karin L. Klingman(National Institutes of Health), Tricia H. Burdo(Temple University), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Saeyun Lee(Massachusetts General Hospital), Beverly Alston‐Smith(Cancer Research And Biostatistics), Myron A. Waclawiw(National Institutes of Health), Markella V. Zanni(Harvard University)
Cited by 63
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k